CitraFlow™ 4% SF for Vascular Access Device locking

MedXL

SKU Select options
(No reviews yet) Write a Review
$1,044.44 - $1,733.33
View full description ↓
  • Healthcare-grade equipment
  • Canada-wide shipping
  • B2B & bulk pricing available
Adding to cart… The item has been added
Secure checkout with:
Visa Mastercard American Express Apple Pay Google Pay PayPal
Ordering for a clinic, EMS, or facility? Use “Add to Quote” or contact us for tailored volume pricing.
Why EMRN?

Supplying clinics, EMS, long-term care and home-care across Canada with trusted equipment.

Product details

EMRN MEDICAL SUPPLIES · MedXL

CitraFlow™ 4% SF for Vascular Access Device locking

CitraFlow™ 4% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 4% trisodium citrate solution, formulated for the safe locking and maintenance of vascular access devices such as central venou

Product Information

CitraFlow™ 4% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 4% trisodium citrate solution, formulated for the safe locking and maintenance of vascular access devices such as central venous catheters. This heparin-free citrate lock solution provides effective anticoagulant protection to help maintain catheter patency and minimize the risk of infection and clot formation.

Manufactured in Canada under rigorous quality and sterility controls, each CitraFlow™ SF syringe is ready-to-use, eliminating the need for preparation or dilution. The smooth-glide plunger and leak-resistant design ensure precise, consistent delivery every time.
The 4% citrate concentration is ideal for routine catheter locking and maintenance in hospitals, dialysis units, infusion centers, and long-term care facilities. CitraFlow™ SF syringes are preservative-free, latex-free, and compatible with a wide range of vascular access devices, providing healthcare professionals with a reliable, standardized solution that enhances patient safety and workflow efficiency.
CitraFlow™ 4% SF prefilled syringes are a proven alternative to heparin for locking indwelling catheters on patients. Sodium citrate avoids the risks associated with systemic heparinization and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.

Models & Options

SKUConfiguration / contentsOrder
006-38543Size: 3ml 4% Sodium Citrate solution USP in a 5ml syringe. 900/CaseAdd to Cart
006-38543‐1Size: 4% SF, 3ml 4% Sodium Citrate solution USP in 5ml syringe, twinpack. 600/CaseAdd to Cart
006-38540Size: 4% SF, 5ml 4% Sodium Citrate solution USP in 5ml syringe. 720/CaseAdd to Cart
006-38553Size: 4% SF, 3ml 4% Sodium Citrate solution USP in 10ml syringe. 600/CaseAdd to Cart
006-38555Size: 4% SF, 5ml 4% Sodium Citrate solution USP in 10ml syringe. 600/CaseAdd to Cart

FAQs

What is CitraFlow™ 4% SF for Vascular Access Device locking used for?

CitraFlow™ 4% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 4% trisodium citrate solution, formulated for the safe locking and maintenance of vascular access devices such as central venous catheters. This heparin-free citrate lock solution provides effective anticoagulant protection to help maintain catheter patency and minimize the risk of infection and clot formation.

Which sizes or configurations can I order?

006-38543 — Size: 3ml 4% Sodium Citrate solution USP in a 5ml syringe. 900/Case; 006-38543‐1 — Size: 4% SF, 3ml 4% Sodium Citrate solution USP in 5ml syringe, twinpack. 600/Case; 006-38540 — Size: 4% SF, 5ml 4% Sodium Citrate solution USP in 5ml syringe. 720/Case.

Is this a saline flushing syringe or a catheter-lock solution?

CitraFlow is a vascular-access locking solution, not the same product as Praxiject 0.9% saline. Select the prescribed formulation and concentration according to institutional protocol and the product instructions.

Where are the official manufacturer instructions?

Open the MedXL product page or documentation index from the Documents & Resources tab, and verify the instructions for the exact reference number.